QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Plans to Present at the June 2020 Virtual Investor Summit

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the June 2020 Virtual Investor Summit slated to take place June 9-12, 2020. According to the update, Trxade Group management is scheduled to present at 10:20 AM ET (7:20 AM PT) on Tuesday, June 9, 2020, and will host virtual one-on-one investor meetings throughout the event. Conference participation is by invitation only and registration is mandatory. Please contact your conference representative for more information or to schedule a virtual one-on-one meeting.

To view the full press release, visit http://ibn.fm/T97q7

About Trxade Group, Inc.

Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms; (1) the Trxade B2B trading platform with 11,400 registered pharmacies, (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division, (3) the Bonum Health platform offering affordable telehealth services; and (4) the DelivMeds app, which coordinates a nationwide distribution network through independent pharmacies or mail order delivery. For additional information, please visit www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

Uber Technologies Inc. (NYSE: UBER) Rolls Out New Hourly Rate Option in Continuation of Pandemic, Social Unrest Measures

- Uber Technologies has used its open-access model for facilitating transit to revolutionize how the world’s citizens move around, operating its ride-sharing solutions in 67 countries
- The company recently introduced a pricing alternative that allows riders to pay for multiple stops at a single, hourly rate in select metropolitan cities beginning June 2
- The hourly rate replaces a model in which riders had to select new service after arriving at each destination, complicating the plans of those customers who needed to complete essential errands
- The new option is a timely response to the disruption of public transportation by forces including the deadly coronavirus pandemic, as well as the upheaval during rioting and social unrest in response to recent events within the United States

Pioneering transportation facilitator Uber Technologies Inc. (NYSE: UBER) is developing a new errand-running option for riders that shows the company’s responsiveness to customer needs at a time when numerous market disruption forces are challenging businesses’ efforts to keep operations in motion.

Uber’s announcement that it will allow riders to select a single $50 per hour rate with multiple stops in select cities (http://ibn.fm/HFj1v) provides an alternative for public transportation customers who’ve found their routines disrupted by daunting forces such as the ongoing global COVID-19 pandemic and recent rioting in many metropolitan cities.

“At Uber, we are always thinking about how we can make people’s lives easier by developing products that solve new challenges,” the company stated in a recent news release about family-centric changes to its meal delivery services (http://ibn.fm/rMlc6).

Uber has allowed riders to request multiple destinations in one trip since 2017 but it was previously necessary for them to re-request a new trip after visiting each location if they wanted to run errands to multiple stops, according to a report on the decision in The Verge (http://ibn.fm/pIrFu).

The single fee for multiple stops service rolled out June 2 in Atlanta, Chicago, Dallas, Houston, Miami, Orlando, Philadelphia, Phoenix, Seattle, Tacoma, Tampa Bay and Washington, D.C. It matches the riders with a driver who has a more spacious and newer model of vehicle that is eligible for Uber Comfort, according to the company.

Uber has introduced several new initiatives during recent weeks to support its own drivers as well as members of the general public attempting to continue performing essential tasks during the pandemic, which has seen a highly infectious and often deadly or debilitating virus spread throughout populations around the globe since the beginning of the year (http://ibn.fm/mS2px).

The company provided masks, hand sanitizer and cleaning supplies for its drivers, financial support for drivers who become sick, and information on navigating the varied regulations for public relief under the different governments where Uber’s drivers operate (http://ibn.fm/2MU2c). Riders are also required to wear masks, and drivers limit the number of passengers allowed per vehicle.

Recent unrest as a result of widespread anger over a black man’s death while in police custody led to the shutdown of public transportation in many of the United States’ metro areas, further disrupting transit (http://ibn.fm/uhiwH) while directing ridership to Uber drivers providing essential services (http://ibn.fm/Nh9Je).

Uber’s director of rider operations, Niraj Patel, said the new hourly multi-stop rate is “an additional earnings opportunity for drivers” in the company’s announcement, noting the customer will be asked to select how long the trip will last before confirming the ride and will end up paying for the time selected even if the trip actually takes less time.

Customers will also be charged a per-minute rate if their trips go over the time limit, or a per-mile rate for trips that go over the mileage limit. The company first tested the strategy in countries like Australia, Africa, Europe, and the Middle East, and plans to extend it to additional cities in the United States during the coming weeks as it determines the response from riders.

For more information, visit the company’s website at www.Uber.com

QualityStocksNewsBreaks – Spectrum Global Solutions, Inc. (SGSI) Eliminates Over $500K of Convertible Debt

Spectrum Global Solutions (OTCQB: SGSI), a leading single-source technology and services provider specializing in next-generation energy management, professional engineering and communications network infrastructure solutions, today announced that it has instituted several cost cutting measures and was able to eliminate over $500,000 of convertible debt that would have been toxic to the company’s common stock. “The elimination of toxic debt, the tightening of our belts, and the strengthening of our balance sheet, is an on-going focus for the company and will continue to be so as we manage through these trying times,” Spectrum CEO Roger Ponder said in the news release.

To view the full press release, visit http://ibn.fm/dbAKD

About Spectrum Global Solutions

Spectrum Global Solutions (OTCQB: SGSI) is a leading single-source technology and services provider, specializing in next-generation energy management, professional engineering, and communications network infrastructure solutions. Spectrum’s highly scalable service platform model, proven out through engagements with tier-1 network operators in the United States, Canada, Caribbean, Europe, Africa and Asia uniquely allows for the bundling of disparate services and technology products with a single provider, simplifying network deployment and maintenance with a comprehensive, cost-competitive one-stop-shop solution. For more information, visit the company’s public filings at SEC.gov or its website at www.SpectrumGlobalSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to SGSI are available in the company’s newsroom at http://ibn.fm/SGSI

QualityStocksNewsBreaks – Cannabis Global, Inc. (MCTC) Discusses Strong Solution with Expected 50%+ Cost Advantage in Production of THC-V and Other Rare Cannabinoids

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today announced information on its Project Varin, a nearly complete research program implemented to develop novel production technologies for rare cannabinoids, including tetrahydrocannabivarin (“THC-V”), which is not scheduled at the federal level. According to the update, the program has produced meaningful technology breakthroughs resulting in several patent filings. The company has been able to leverage these technological developments to significantly reduce the cost of exotic cannabinoids on a per-serving basis resulting in a greater than 50% expected cost advantage. “We think we have rewritten the exotic cannabinoid cost equation via our Project Varin. The minor exotics represent a new cost challenge for the industry, and we believe we have developed a strong and defensible solution,” Arman Tabatabaei, CEO of Cannabis Global, stated in the news release. “Acquiring THC and CBD from plants within the Cannabaceae family is relatively easy as these cannabinoids are produced by nature in abundance. It is a very different issue relative to THC-V, CBN, and other exotics. With our patent pending technologies, we have been able to rewrite the cost equation for minor cannabinoids, while at the same time moving well beyond the purity possible from legacy technologies. While we are already at a 50% cost advantage to the competing technologies, most of which are still theoretical and not yet available on the market, we believe further travel down our cost curve is possible as we move into high volume manufacturing this month.”

To view the full press release, visit http://ibn.fm/aFYfy

About Cannabis Global, Inc.

Cannabis Global, Inc., formerly known as MCTC Holdings, Inc., is a fully audited and reporting company with the U.S. Securities & Exchange Commission, trading with the stock symbol MCTC. The company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp and cannabis infusion technologies. The company does not engage in the production, distribution, or sales of any controlled substances, including marijuana. The company has an actively growing portfolio of intellectual property having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The company markets its consumer products under the Hemp You Can Feel brand name. Cannabis Global launched is Project Varin early in 2020, to develop new delivery methods for rare cannabinoid Tetrahydrocannabivarin (“THC-V”) and to develop products based on this cannabinoid. For more information, visit the company’s website at www.CannabisGlobalInc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://ibn.fm/MCTC

QualityStocksNewsBreaks – Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Eyes Opportunity Amidst Increased Investment into Indonesia’s Battery Metals Supply Chain

Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE), an Indonesia-based company focused on developing battery mineral projects in the Asia-Pacific region, today noted reporting by the Financial Times that Huayou Cobalt (“Huayou”), “China’s top cobalt producer halts buying from Congo miners.” The Democratic Republic of Congo (the “DRC”) has been widely reported to represent 60% of global cobalt production. Huayou, which supplies cobalt to battery makers LG Chem of South Korea and CATL of China, as well as Chinese carmaker BYD and Germany’s Volkswagen, is the latest conglomerate to exit the DRC, joining Apple, Google and several auto manufacturers. According to the update, Huayou is looking to raise $870m in an effort to expand nickel and cobalt sulphate production in Indonesia, with its Morowali Industrial Park plant expected to produce at least 60,000 tonnes of annual nickel content within two years. “Cobalt remains an important ingredient in battery chemistries, and international markets are increasingly demanding conflict-free sources for the metal,” Bolt Metals CEO Ranjeet Sundher stated in the news release. “Bolt Metals believes Indonesia represents a unique opportunity to exploit cobalt as a byproduct of the country’s abundant nickel resources. Our flagship Cyclops nickel-cobalt asset has demonstrated strong results from 2018-19 drilling and benchmark analysis, providing an essential foundation for the eventual development of a pilot plant.”

To view the full press release, visit http://ibn.fm/2RRgu

About Bolt Metals Corp.

BOLT Metals is a Canadian-based exploration company focused on the acquisition and development of production grade nickel and cobalt deposits, key raw material inputs for the growing lithium-ion battery industry. For more information, visit the company’s website at www.BoltMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to PCRCF are available in the company’s newsroom at http://ibn.fm/PCRCF

QualityStocksNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Announces Update on Insolvency Proceedings Under the CCAA

Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) and certain of its direct and indirect wholly owned subsidiaries (collectively “GGB”, the “company” or the “Applicants”) on Tuesday released an update on its insolvency proceedings under the Companies’ Creditors Arrangement Act (Canada) (“CCAA”). As announced on May 20, 2020, GGB filed for insolvency protection under the CCAA and obtained an order from the Ontario Superior Court of Justice (the “Court”) granting protection for an initial 10 day period until May 29, 2020, as extended until June 12, 2020. According to the update, the Court, on June 2, 2020, granted a motion filed by the company and issued an order. The “Amended and Restated Order”: (i) extends the stay period until August 15, 2020; (ii) increases the amount of the Court-ordered charge over the Applicants’ assets, property and undertakings in connection with the Applicants’ debtor-in-possession financing agreement with All Js Greenspace LLC (“All Js”) (the “DIP Agreement”); (iii) approves the implementation of a sale and investment solicitation process (the “SISP”); and (iv) approves a stalking-horse agreement among the company, All Js and Capital Transfer Agency in its capacity as the debenture holder trustee of the company’s (A) US$45,500,000 aggregate principal amount of 15.00% secured convertible debentures that matured May 17, 2020 and (B) US$23,717,000 aggregate principal amount of 5.00% secured convertible debentures maturing in 2024 (All Js and Capital Transfer Agency in such capacities are collectively referred to as the “Secured Credit Bidders”) pursuant to which the Secured Credit Bidders would act as stalking-horse bidders under the SISP.

To view the full press release, visit http://ibn.fm/QK7ao

About Green Growth Brands Inc.

Green Growth Brands creates remarkable experiences in cannabis. The company’s brands include CAMP, The+Source, and 8 Fold. GGB is expanding its cannabis operations throughout the U.S., via dispensaries in Nevada, Massachusetts and Florida. For more information, visit the company’s website at www.GreenGrowthBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://ibn.fm/GGBXF

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Acquires Soluble Therapeutics, Inc. and BioDtech, Inc.

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, on Tuesday announced the completion of the acquisitions of two wholly owned subsidiaries of InventaBioTech, Inc., Soluble Therapeutics, Inc. and BioDtech, Inc. Included in the acquisition were certain intellectual property relating to contract research organization (“CRO”) services and technology, certain equipment useful in such services and technology and all other assets of Soluble Therapeutics and BioDtech. In consideration, POAI issued 125,000 shares of common stock and waived all remaining amounts due and payable to the company under a secured promissory note of InventaBioTech in the principal amount of $1,070,000. “These two acquisitions meaningfully expand revenue and monetization prospects for our precision medicine business. First, the Soluble Therapeutics assets increase the company’s capabilities to provide services for the pharmaceutical and biotech industries and predict and provide the best formulation with the highest concentration and the most stable solution for protein and peptide-based drugs. Second, the company’s purchase of BioDtech’s assets provides it with ownership over BioDtech’s successfully developed test used to ‘unmask’ endotoxins, which allows a monitoring physician to perhaps change the strategy of treatment or treat the patient with antibiotics. These acquisitions will allow Predictive Oncology to further maximize opportunities within the company’s precision medicine business,” Predictive Oncology CEO and Director Dr. Carl Schwartz stated in the news release.

To view the full press release, visit http://ibn.fm/iQCUr

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (domestic, international and other) that contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient-treatment decisions by providing an evidence-based road map for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled with a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform Kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient-specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

Predictive Oncology Inc.’s (NASDAQ: POAI) Subsidiary a ‘Major Asset’ in Growing Precision Medicine Space

- POAI addresses pressing need for a multi-omic approach in field of precision medicine
- Global precision medicine market is expected to reach total market value of approximately $84 billion by 2026
- Predictive Oncology’s ‘claim to fame’ is its inventory of over 150,000 tumors covering over 137 types of cancer, with over 30,000 related to ovarian cancer

In the burgeoning world of precision medicine, Predictive Oncology Inc. (NASDAQ: POAI) appears ideally positioned to address one of the most pressing problems in the industry: the need for a multi-omic approach to precision therapy that may offer markedly improved patient outcomes over just genomics alone. POAI, a leader in the cancer precision-medicine field, has a “major asset” in its Helomics subsidiary, which specializes in ovarian cancer. Through its unique patient derived (PDx) platform, which tests the drug response and biomarker profile of the patient’s own tumor, and its vast database of historical tumor profiles, Helomics provides clinical decision support tools today to assist oncologists in individualizing cancer treatment.

Precision medicine is based on the idea of customizing health care, making medical decisions and selecting treatments, practices and prescriptions that are tailored to each individual patient rather than a recommended general treatment approach. A recent Acumen Research and Reporting article noted that the global precision medicine market is expected to reach total market value of approximately $84 billion by 2026 with anticipated CAGR growth of around 10% in terms of revenue between 2019 and 2026 (http://ibn.fm/vufVR).

That growth hasn’t gone unnoticed. Big pharma has invested heavily in precision medicine, focusing its efforts on genomics and “big data” to understand each patient’s genome in order to deliver targeted therapeutics. “Success rates for these targeted therapies are low, and uptake in clinical practice is patchy,” POAI reports on its website (http://ibn.fm/MywNK), noting a growing realization that “just genomics is not enough to achieve the promise of personalized therapeutics. A clear need has emerged for a multi-omic approach that may offer a much greater chance of success. However, few comprehensive, multi-omic data sets exist, and such data is difficult to access quickly as it is both costly and time consuming to initiate prospective data collection — especially in cancer.”

Multiomics, or the use of multiple omics technologies (i.e., genome, proteome, transcriptome, epigenome, microbiome, etc.) to study disease in a more comprehensive manner has significant implications in the world of health care – and Predictive Oncology owns powerful data and technology that may make the company a clear frontrunner in the precision medicine space.

“Predictive’s major asset is its subsidiary Helomics, and its claim to fame is its inventory of over 150,000 tumors covering over 137 types of cancer, with over 30,000 related to ovarian cancer, which is sort of our specialty. In fact, this is the largest inventory of its kind in the world,” POAI director and CEO Carl Schwartz stated in a news release (http://ibn.fm/e9EIC).

Furthermore, the data in POAI’s molecular information platform are highly differentiated, the company explained, containing both drug-response and biomarker data and with access to historical outcome data from these individual patients. Predictive Oncology is working to gather additional sequence data (mutation and gene expression) from these tumor samples, coupling this with its unique drug response profiles to build AI-driven predictive models of cancer that it believes will meet the unmet market need for a multi-omic approach to the development of new drugs and improve patient outcomes.

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through the company’s Helomics division, the company leverages its unique, clinically validated patient derived (PDx) smart tumor profiling platform to provide oncologists with a road map to help individualize therapy.

In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow

For more information, visit the company’s website at www.Predictive-Oncology.com

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

National Storm Recovery Inc. (NSRI) Positioning Itself as the Sustainable Green Team

- “Sustainability has become a business imperative for all companies,” reports WEF article
- NSRI’s Sustainable Green Team solutions are founded in sustainability, begin with the collecting of tree debris
- “The importance of our shared belief that we are ‘stewards of the environment’ should not be understated,” says Mulch Manufacturing CEO

A recent World Economic Forum (WEF) article (http://ibn.fm/SQk29) stated that “sustainability has become a business imperative for all companies.” National Storm Recovery Inc. (OTC: NSRI), a provider of storm/disaster recovery services, takes that imperative seriously and is committed to positioning itself as the Sustainable Green Team, as noted by CEO Tony Raynor (http://ibn.fm/Srkwk).

NSRI’s recent acquisition of Mulch Manufacturing was the latest step in National Storm Recovery’s commitment to providing environmentally friendly products to the public. “With Mulch Manufacturing’s national and international distribution, its sales contracts with many big box retailers, and the increase in production and packaging capacity it provides, this strategic acquisition has positioned us as the Sustainable Green Team,” Raynor stated in a news release.

National Storm Recovery’s Sustainable Green Team solutions are founded in sustainability. The company’s vertically integrated operations begin with the collecting of tree debris through its tree-services division and collection sites, then recycling the debris into a feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers.

“The importance of our shared belief that we are ‘stewards of the environment’ should not be understated,” Mulch Manufacturing’s CEO Ralph Spencer agreed. “National Storm’s strategic partnership with one of the largest waste disposal companies in the country doesn’t just drive revenue while it secures mulch feedstock, the use of this feedstock has the environmental benefit of decreasing the volume of material that would otherwise continue to fill our nation’s landfills, and these are just [a few] examples of why this business combination makes so much sense.”

The WEF report, written by Karen Quintos, noted that “we know investment opportunity in sustainability is only growing bigger. The projects and programs being led by individual businesses are moving the needle. This is especially true when you combine sustainability investments with the unique products or services of your business, the talents of your people and the capabilities of your customers and partners. I call this your company ‘secret sauce.’ By bringing these resources together, today’s businesses have made significant progress in recovering materials, cleaning oceans and reducing our footprint.”

Certainly NSRI’s “secret sauce” is rooted in its commitment to sustainability, expert products and services, and the talents and skill sets of its people. “For more than 40 years, our team has dedicated our time to perfecting and honing our techniques,” states the NSRI website. “With the best equipment, most effective strategies, and a true dedication to customer service, we know we are the best team for the job.”

NSRI’s commitment is to environmentally beneficial solutions to tree and storm-waste disposal (http://ibn.fm/ri1RC). For investors, the company plans to expand its operations through a combination of organic growth, including its partnership with a nationally recognized waste disposal company and via strategic acquisitions. NSRI’s next-level experience with mulch manufacturing, treatment and caring for trees sets it on the right course for sustained growth.

For more information, visit the company’s website at www.NationalArborCare.com

NOTE TO INVESTORS: The latest news and updates relating to NSRI are available in the company’s newsroom at http://ibn.fm/NSRI

QualityStocksNewsBreaks – Wildflower Brands Inc. (CSE: SUN) (OTC: WLDFF) Announces $5.3 Million in Revenues for Q3

Wildflower Brands (CSE: SUN) (OTC: WLDFF) today announced $5.3 million in revenues in its third quarter, compared to $2.5 million in the previous year’s third quarter and $5.5 million in the second quarter. According to the update, revenues were slightly less than last quarter; however, even with unforeseen circumstances and business affected by Covid-19, Wildflower was able to operate with a net gain of $101,435 compared to a loss of $(1,019,862) in the third quarter of 2019. Wildflower’s U.S. operations have been curtailed due to the closure of many retail locations where the Company’s products are sold. Manufacturing and sales activities have been scaled back to align Wildflower’s resources with the current business environment. The Company is also investigating government sponsored assistance programs to support its employees and their families.

To view the full press release, visit http://ibn.fm/1NsnM

About Wildflower Brands Inc.

Wildflower Brands is a Vancouver-based company developing and designing brands that focus on plant-based health and wellness products. All of the company’s brands work in synergy, toward becoming a global wellness leader. For more information about Wildflower Brands, visit www.WildflowerBrands.co. To learn, engage and shop for wellness products visit www.BuyWildflower.com.

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Subsidiary to Provide Consumers, Dealers Access to Extensive Lease Financing

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) this morning announced that MUSA Auto Finance, LLC (“MUSA”), its 60% controlled leasing platform in the United States, is expected to commence lease originations on its proprietary cloud-based platform for consumers and auto dealers in June. MUSA will enable consumers and dealers to access extensive funding facilities from national financial institutions through the platform, which is accessible on smart phones and other digital devices. In addition, the company has agreed to make PowerBand’s virtual transaction platform, which includes MUSA, available to thousands of dealerships working with RouteOne LLC in the United States and Canada. RouteOne offers a broad range of finance and insurance tools, including credit applications, eContracting, digital retail and compliance. “This is a major advancement for MUSA and PowerBand,” MUSA Auto Finance CEO Jeff Morgan stated in the news release. “We have a proprietary auto lease platform that we believe is the first of its kind, and now we are finalizing exclusive agreements, with national financial institutions, so we can roll out our technology to dealers and consumers nationally.”

To view the full press release, visit http://ibn.fm/mwt3t

About PowerBand Solutions Inc.

PowerBand Solutions, listed on the TSX Venture Exchange and the OTCQB markets, is a fintech provider disrupting the automotive industry. PowerBand’s integrated, cloud-based transaction platform facilitates transactions among consumers, dealers, funders and manufacturers (“OEMs”). The platform enables these entities to buy, sell, trade, finance and lease new and used, electric and nonelectric vehicles on smartphones or other online digital devices from any location. PowerBand’s transaction platform —trademarked under DRIVRZ — is being made available across North American and global markets. For more information, visit www.PowerBandSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to PWWBF are available in the company’s newsroom at http://ibn.fm/PWWBF

QualityStocksNewsBreaks – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) to Secure $11.25 Million in Bought Deal Public Offering

Cardiol Therapeutics (TSX: CRDL) (OTCQX: CRTPF), a leader in the production of pharmaceutical cannabidiol (“CBD”) and the development of innovative cannabidiol products for heart diseases, recently announced its entry into an agreement with Canaccord Genuity Corp. (the “Lead Underwriter”). Under the arrangement, the Lead Underwriter agreed, on behalf of a syndicate of underwriters, to purchase, on a bought deal basis per the filing of a short form prospectus, an aggregate of 4,500,000 units, each at a price of $2.50, for aggregate gross proceeds of $11,250,000 to the Company. Cardiol intends to use the proceeds to support commercialization of its pharmaceutical cannabidiol products, its ongoing research and clinical development programs focused on heart failure, additional product development, as well as for general corporate purposes.

To view the full press release, visit http://ibn.fm/Pe1B9

About Cardiol Therapeutics

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) is focused on producing pharmaceutical cannabidiol (“CBD”) products and developing innovative therapies for heart diseases, including acute myocarditis and other causes of heart failure. The Company’s lead product, CardiolRx(TM), is formulated to be the most consistent cannabidiol formulation on the market. CardiolRx is pharmaceutically produced, manufactured under cGMP, and is THC free (<5 ppm). The Company also plans to commercialize CardiolRx in the billion-dollar market for medicinal cannabinoids in Canada and is pursuing distribution opportunities in Europe and Latin America.

In heart failure, Cardiol is planning an international clinical study of CardiolRx in acute myocarditis, a condition caused by inflammation in heart tissue, which remains the most common cause of sudden cardiac death in people less than 35 years of age. The Company is also developing proprietary nanotechnology to uniquely deliver pharmaceutical cannabidiol and other anti-inflammatory drugs directly to sites of inflammation in the heart associated with heart failure. Heart failure is the leading cause of death and hospitalization in North America with associated annual healthcare costs in the U.S. alone exceeding $30 billion. For further information about Cardiol Therapeutics, please visit CardiolRX.com.

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Engages PCG of New York for IR and Digital Marketing Services

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, on Monday announced that it has retained PCG Advisory, Inc. (“PCG”) of New York, to provide investor relations and digital marketing services to the Company in compliance with regulatory guidelines. According to the update, PCG’s sectors of deepest experience include life sciences, technology and cannabis, and it reaches thousands of individual, retail and institutional investors daily using the latest social media and digital marketing techniques. PCG will develop a comprehensive strategy to increase investor awareness of Lexaria, amplify market visibility, and introduce the Company to its proprietary investment community network that includes institutional funds, banks, analysts and brokers.

To view the full press release, visit http://ibn.fm/g0sOc

About Lexaria

Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

QualityStocksNewsBreaks – Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF) Posts Q1 2020 Financial Results

Exro Technologies (CSE: XRO) (OTCQB: EXROF), a clean-tech company committed to transforming energy conversion to enhance the performance, efficiency and longevity of electric motors, on Monday announced financial and operational results for the three months ended March 31, 2020. Per the release, the company incurred a comprehensive loss of C$1,525,182 during the quarter. The company also reported that it incurred C$175,882 in research and development for the quarter, which primarily represents materials used for development of its technology as Exro continues to advance toward its goals for commercialization. “Exro is in full force at commercializing its patented Coil Switching Technology. We engaged multiple partnerships with manufacturers during the first quarter such as Finland’s Aurora Powertrains Oy (“Aurora”) and Clean Seed Capital Group Ltd. (“Clean Seed”) along with the partnerships from 2019, Motorino Electric Bike, Potencia and Templar Marine. We are in talks with several potential partners to build prototypes that will be implanted into the field,” Exro Technologies CEO Sue Ozdemir stated in the news release. “We are also in works to open a 6,500 sq. ft. innovation center in Calgary, Alberta, to demonstrate how the company dramatically improves the performance of the world’s electric motors. The Exro Innovation Center (“EIC”) will also increase the company’s laboratory space, to expand its service capabilities to customers and showcase where Exro’s technology can be applied to key sectors of the economy. The EIC will also host collaborative events to explore advances in energy consumption and power electronics innovations, with participants from Calgary, across Canada and around the world.”

To view the full press release, visit http://ibn.fm/guZaZ

About Exro Technologies Inc.

Exro is a clean-tech company that has developed a new class of control technology for electric powertrains. Exro’s advanced-motor control technology, or Coil Driver, expands the capabilities of electric motors and powertrains. Coil Driver enables two separate torque profiles within a given motor. The first is calibrated for low speed and high torque while the second provides expanded operation at high speed. The ability to change configuration allows efficiency optimization for each operating mode, resulting in overall reductions in energy consumption. The controller automatically and seamlessly selects the appropriate configuration in real time so that torque demand and efficiency are optimized.

The limitations of traditional electric machines and power technology are becoming more evident. In many increasingly prominent applications, traditional methods cannot meet the required performance. This means either oversizing the equipment, adding additional motors or implementing heavy mechanical-geared solutions. Exro offers a new solution for system optimization through implementation of its technology, which can yield increased drive cycle efficiency, reduced system volume, reduced weight, and expanded torque and speed capabilities. Exro allows the application to achieve more with less energy consumed. For more information, visit the company’s website at www.Exro.com.

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

QualityStocksNewsBreaks – The Movie Studio Inc. (MVES) Inks Licensing, Distribution Agreement with FILMHUB

Vertically integrated motion-picture production company The Movie Studio (OTC: MVES) announced in April that it signed a licensing and distribution agreement with FILMHUB, an online marketplace for film creators and streaming services (http://ibn.fm/LLdvn). An article discussing the company reads, “In addition, the Movie Studio will license its catalog to FILMHUB for distribution by way of its online film marketplace. . . . ‘We are excited to begin to offer hundreds of titles on our OTT platform in addition to licensing our titles to FILMHUB and its associated OTT partners,’ MVES studio president and CEO Gordon Scott Venters stated in a news release. ‘As we continue to grow shareholder equity by acquisition and strategic partnerships, we believe FILMHUB is a perfect partner for continued growth. We look forward to a long and mutually profitable and beneficial partnership.’ . . . FILMHUB of Santa Monica, California, has its modern, technology-driven B2B (business to business) marketplace for filmmakers to reach streaming channels worldwide. FILMHUB has more than 12,000 titles available for licensing to more than 100 channels.”

To view the full article, visit http://ibn.fm/H9UwY

About The Movie Studio Inc.

The Movie Studio operates as a vertically integrated motion-picture production and distribution company. The company acquires, develops, produces and distributes independent motion-picture content for worldwide consumption via theatrical release, video on demand, foreign sales and various media devices. MVES is disrupting traditional media-content delivery systems with its digital business model of motion picture distribution and intends direct server access of its content with geofractured territories for worldwide distribution. The company was formerly known as Destination Television Inc. and changed its name to The Movie Studio Inc. in November 2012. The Movie Studio Inc. was founded in 1961 and is headquartered in Fort Lauderdale, Florida. For more information, visit the company’s website at www.TheMovieStudio.com.

NOTE TO INVESTORS: The latest news and updates relating to MVES are available in the company’s newsroom at http://ibn.fm/MVES

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Applies Unique Database to Improve Cancer Outcomes

Predictive Oncology (NASDAQ: POAI), through its Helomics subsidiary, is leveraging its proprietary database of more than 150,000 tumor genomic and drug response profiles to improve cancer outcomes. An article discussing the company reads, “With a mission to improve the standard of care for cancer patients, Helomics’ TruTumor(TM) platform harnesses the power of the patient’s own living tumor to address challenges oncologists often face when assessing patients and individualizing treatments. The clinically validated (in ovarian cancer) cell-based functional platform is in use today and profiles patient tumors, identifying key biomarkers and how the tumor responds to drugs and helps the oncologist determine a tailored therapy for that patient. . . . Helomics’ is building AI-driven predictive models by leveraging a unique database of 150,000 tumor genomic and drug response profiles gathered from over 15 years of clinical testing using its TruTumor platform, access to over 15 years of outcome data from a national network of oncologists, plus a physical biobank of tumor samples that is being sequenced as part of its CancerQuest 2020 initiative (http://ibn.fm/B9mmE) to generate rich genomic profiles.”

To view the full article, visit http://ibn.fm/4G1qF

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (domestic, international and other) that contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient-treatment decisions by providing an evidence-based road map for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled with a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform Kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient-specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Providing Premium Medical Teleconferences

Trxade Group (NASDAQ: MEDS), through its virtual healthcare subsidiary Bonum Health, provides telehealth services and prescription ordering via teleconferences that are conducted using smart devices. A recent article discussing the company reads, “The service provides subscribers with three premium medical teleconferencing visits through Bonum Health and prescription delivery through the company’s DelivMeds same day/mail-order pharmaceuticals service each month under the standard membership rate. . . . ‘With the seasonal flu outbreaks and the current coronavirus surge, patients are quick to brush off common symptoms, including cough, fever and body aches, as signs of a common cold; Telemedicine removes the barrier of self-doubt and complacency in the current climate of worldwide viral infections,’ the company stated in a news release (http://ibn.fm/BrWLY).”

To view the full article, visit http://ibn.fm/UaikR

About Trxade Group Inc.

Headquartered in Tampa, Florida, Trxade Group is an integrated drug-procurement, delivery and healthcare platform that enables price transparency and increased profit margins to buyers and sellers of pharmaceuticals, makes healthcare services affordable and accessible across all 50 states, and steps in to meet today’s immediate demands. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms: the Trxade B2B trading platform with 12,100 registered pharmacies, a licensed virtual wholesaler, affordable healthcare via its Bonum Health app or web-based telehealth services, and same-day or mail-order pharmacy-delivery capabilities via its DelivMeds app featuring its extensive nationwide distribution network. For additional information, please visit www.Trxade.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) and Source Digital Join Forces to Promote Auto Trading Platform

- Source Digital has worked with numerous Fortune 500 companies to help create a more effective video advertising experience
- Company’s innovative advertising platform is designed to increase customer engagement and ROI
- PowerBand’s cloud-based auto trading platform offers a convenient, efficient and safe option for buyers and dealers to buy, sell, lease and trade vehicles online, eliminating unnecessary middlemen

Through a recently announced partnership, PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) and Source Digital will join forces to promote PowerBand’s innovative auto trading platform that provides car buying and financing trucks with never-seen-before simplicity, speed, and cost-efficiency. The trading platform will be promoted via Source Digital’s unique in-video advertising platform, designed to provide an enhanced viewer experience, help customers improve their return on investment while offering an overall more engaging and enjoyable experience for customers and users.

Source Digital is a pioneer in immersive commerce, essentially revolutionizing video advertising with its platform. The company has made great efforts to transform video advertising considering how disengaged and impatient viewers have become with it. Source spent seven years working on a video advertising system that engages viewers without disrupting their experience. The company has worked with numerous Fortune 500 companies to create a more engaging and effective video advertising experience. Its network can pull targeted content from multiple sources including sports channels and influencers.

“We are happy to announce our partnership with Powerband Solutions,” Source Digital CEO Hank Frecon said, according to a company news release (http://ibn.fm/vtQI3). “We trust that we will bring value to their system and provide a better user experience at the same time.” Under the agreement, Source Digital will enhance PowerBand’s platform by helping create a more engaged experience for viewers. Source’s advertising platform will deliver the entire car loan approval process into consumer videos.

The partnership will help PowerBand Solutions roll out its platform across the United States. The cloud-based auto-transaction platform successfully addresses a growing demand to sell and buy vehicles online to enhance convenience and adhere to the social distancing restrictions enforced by the ongoing pandemic. According to the Digital Commerce 360 Online Vehicle Shopper 2019 survey, 49% of buyers are willing to purchase a new vehicle entirely online, while Frost & Sullivan estimates that consumers will be able to purchase as many as 1.3 million vehicles online annually as soon as 2035 (http://ibn.fm/QCgmZ).

Developed by a team of experienced automotive, technology and finance experts, PowerBand Solutions’ platform was created around the core belief that consumers preferred to conduct automotive transactions online and avoid interactions with unnecessary middlemen. The platform allows consumers to sell, buy, lease, auction and finance vehicles with never-seen-before simplicity, speed and cost-efficiency from their smart phones or other devices, irrespective of their location.

PowerBand has already successfully launched and conducted “virtual” auctions in the United States together with and D2D Auto Auction LLC. D2D is co-owned by PowerBand and Arkansas-based financier Bryan Hunt, director of J.B Hunt Transport. The highly successful virtual auctions testify to the speed and efficiency of D2D’s unique transaction platform (http://ibn.fm/rTPEW).

The company is working on commercializing its platform to consumers and automotive dealers and to this end, it has secured a commitment of up to $10-million in investment from Texas-based D&P Holdings Inc. – one of the largest administrators of automotive warranty and insurance products in the United States, working with more than 850 dealerships nationwide (http://ibn.fm/ATuWl).

For more information, visit the company’s website at www.PowerBandSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to PWWBF are available in the company’s newsroom at http://ibn.fm/PWWBF

Sigma Labs Inc. (NASDAQ: SGLB) Stands to Benefit from Post-Epidemic Trends Aimed at Strengthening Manufacturing, Supply Chain

-COVID-19 exposed weaknesses in manufacturing, supply chain spaces; 3D printing offers ideal solution
-3D-metal-printing presents its own mechanical hurdles, including quality issues undetected until postproduction
-SGLB’s patented PrintRite3D(R) software provides solution to costly quality-control challenges that impede manufacture of precision 3D-metal parts

Among the many changes wrought by COVID-19, those within the manufacturing and supply chain sectors will likely be far reaching and long lasting. The epidemic has exposed fundamental weaknesses in the system, some of which may be solved through advanced software and technologies, including 3D metal printing. Sigma Labs Inc. (NASDAQ: SGLB), a leading developer of quality-assurance software in the commercial 3D-metal-printing space, may benefit from the trend.

“3D printing has come a long way in recent years, with manufacturing times improving,” a recent Forbes article reads (http://ibn.fm/OB0WW). “The time it takes to print items depends on both the quality of the printer as well as the complexity of the item being printed. As we enter a new era with COVID-19 continuing to disrupt supply chains and causing shortages of essential medical equipment, the 3D printing community is stepping in to help.”

Another article, published by MarketWatch, makes a similar observation. “Out of necessity, manufacturers in the new normal will build factories much closer to where critical parts are needed, reduce the human workforce, and rely more on software and efficiency technologies like 3D printing,” the article reads (http://ibn.fm/EfzTG). “At the epicenter of this sea of change is Sigma Labs, with its revolutionary patented technology that detects and identifies defects and anomalies in real time during the 3D printing process of metal, paving the way for scalability and economic efficiency.”

Both articles point out that additive manufacturing, or 3D printing, speeds production, allows flexibility, and brings new ideas to market quicker at lower cost. However, the new technology is not perfect. “Commercial 3D metal printing is gaining vital importance in the entire global manufacturing sector – yet the efficiency it yields is not without challenges,” the MarketWatch article notes. “A myriad of variables from machines to materials create production hurdles in metal additive manufacturing.”

Among those problems is the fact that the newly printed parts don’t always meet precise specifications. Previously, 3D-metal-printing manufacturers have had to rely on post-production inspection techniques to detect these imperfections, which are both costly and wasteful, since the problem isn’t discovered until the printing is complete, rendering the part unusable.

“With its patented PrintRite3D(R) software, Sigma Labs presents a solution to the costly quality-control challenges that impede the volume manufacture of precision 3D metal parts,” the article continues. “In doing so, Sigma’s software could easily become indispensable in the global efforts to meet the manufacturing challenges of post COVID. The company’s breakthrough software has the potential to bolster and broaden commercial metal-additive manufacturing by enabling for the first time cost-effective, nondestructive quality assurance during the production process. PrintRite3D(R) is the leading technology in identifying and classifying defects and anomalies in-process and allows for errors to be corrected in real time — even remotely.”

Sigma Labs Inc. is a leading provider of quality-assurance software to the commercial 3D-metal-printing industry under the PrintRite3D brand. Sigma specializes in the development and commercialization of real-time monitoring solutions known as PrintRite3D for 3D-metal, advanced-manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real time during the manufacturing process and informs the production manager of quality issues. Sigma Labs’ software product is a major catalyst for the acceleration and adoption of 3D metal printing.

For more information about Sigma Labs, please visit www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

The Movie Studio Inc. (MVES) Joins New Digital Content Marketplace, Sees Number of Films Licensed Within Days

-Video-on-demand (VoD) and streaming services have seen astonishingly high subscriber numbers in 1Q2020
-The Movie Studio has sought to capitalize on rising demand for licensed content by joining online digital marketplace seeking to bring content vendors, distributors together within single platform
-The company revealed that it had already licensed a number of films for territory of Australia within days of joining new platform
-The Movie Studio’s recent licensing efforts as well its vast array of feature films in pre-production put it in good stead to benefit from rapid rise in demand for licensed content

In a recent survey of 2,600 people in the U.S., an astounding 64% of respondents said that they had either severed their ties with their television cable provider or were actively planning to – with the figure rising to 74% within the 18 to 34 age bracket (http://ibn.fm/bHXoK). The ongoing coronavirus pandemic has seen a stark and overwhelming shift by housebound consumers towards streaming video providers, and digital content providers like The Movie Studio Inc. (OTC: MVES) are positioned to capitalize on the shift in consumer demand.

The Movie Studio recently announced its integration with a digital content platform, which seeks to bring together content vendors and distributors into a single digital marketplace. The digital marketplace utilizes smart contracts and blockchain technology to enable its counterparties to transact in a seamless and cohesive manner. Simultaneously, this allows companies to bypass the oft cumbersome and time-consuming process of optioning film rights amongst the vast array of video-on-demand (VoD) platforms prevalent in today’s marketplace.

“We are excited to leverage a digital platform for our current and future aggregated titles and to facilitate title recognition for upcoming movies,” MVES President and CEO Gordon Scott Venters stated in a news release (http://ibn.fm/LeWRi). “This platform allows for geo-fracturing of worldwide distribution rights, isolating our potential revenue streams and allowing for the maximization and monetization of intellectual property rights while the platform eliminates marketing in the physical marketplace, allowing buyers to view our content perpetually in a digital marketplace.”

The VoD market has seen a surge of interest over the past few years, and data released by The Motion Picture Association of America (MPAA) last year revealed that the number of streaming video subscribers had surpassed cable customers for the first time in 2019. The trend has become even more pronounced in 2020, with Netflix announcing that it had added 15.8 million new subscribers in the first quarter of the year – up 23% year-over-year and startlingly, over double the 7 million new subscribers the company had originally forecast (http://ibn.fm/xKRsV). Meanwhile, a recent study carried out by consultancy PwC projected that revenues from digital streaming platforms, also known as over-the-top (OTT) streaming, would rise to over $72.8 billion by 2023 – an annual growth rate of 13.8% (http://ibn.fm/JIcPT). Remarkably, streaming is also set to account for 35.4% of total global TV subscription revenues by 2023, a dramatic increase from the 18.6% share it commanded in 2018.

However, the rapid proliferation of streaming platforms has also led to a sharp increase in demand, and price, for content. While the ongoing and rapid fragmentation of the industry has led to a surge of investment into original programming – Netflix alone is said to direct over 85% of its new content spend towards original and proprietary projects (http://ibn.fm/kTfIF) – PwC found that a remarkable 80% of content viewed within the US was licensed. “While licensed content still attracts many viewers, costs for such content are quickly rising,” concluded Mark McCaffrey, U.S. technology, media, and telecommunications leader at PwC (http://ibn.fm/Fo78k).

The Movie Studio’s unique content library as well as its recent marketing efforts have positioned it well to benefit from the surge of interest in licensed content. On May 22, only days following the company’s integration into the new digital content platform, The Movie Studio revealed that it had licensed a number of its films, including Bad Actress and Exposure, for the territory of Australia (http://ibn.fm/9KuZD). The virtual arms-race for licensed content coupled with the company’s integration into its online digital marketplace has allowed The Movie Studio to accelerate the monetization and revenue stream of its assets whilst simultaneously offering title discovery of feature films in pre-production to a worldwide community of licensors.

The Movie Studio’s efforts, however, have not been limited to its recent successes. In April, the company inked a licensing agreement with FILMHUB, with the latter company charged with distributing the Movie Studio’s extensive film catalog to its broad array of channel partners, including the likes of Amazon and Tubi, among others (http://ibn.fm/7PjQv). With The Movie Studio actively working towards expanding the geographical breadth and scope of its licensing and film library monetization efforts, the company’s recent achievements coupled with its vast array of feature films in pre-production have positioned it optimally to benefit from the breathtaking growth of the online streaming market.

For more information, visit the company’s website at www.TheMovieStudio.com

NOTE TO INVESTORS: The latest news and updates relating to MVES are available in the company’s newsroom at http://ibn.fm/MVES

QualityStocksNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Amended Release Date for Combined YE 2019 and Q1 2020 Financial Results

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced that it will be releasing its Q1 Financial Statements on June 11, 2020 and will be including its 2019 year end results on this day, instead of Wednesday, June 3, 2020, as previously announced. The combined release is intended to give a more representative disclosure of the Company’s financials at once. In addition, the Company will be hosting an investor conference call to discuss the results followed by a Q&A for investors. Siyata Mobile CEO Marc Seelenfreund and VP Sales Glenn Kennedy will host the call, which is scheduled to take place at 9:00 a.m. Eastern (6:00 a.m. Pacific) on Friday, June 12, 2020. Interested parties may join the call by dialing (866) 521-4909 (North America toll free) or (647) 427-2311 (International).

To view the full press release, visit http://ibn.fm/B5eCC

About Siyata
Siyata Mobile Inc. is a B2B global vendor of next generation Push-To-Talk over Cellular (“PTT”) devices and cellular booster systems. Its portfolio of in-vehicle and rugged smartphones enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to improve communication, increase situational awareness and save lives.
Its portfolio of enterprise cellular booster systems enables first responders and enterprise workers to amplify its cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for maximum cellular signal strength possible.
Visit www.SiyataMobile.com and www.UnidenCellular.com to learn more.

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/SYATF

QualityStocksNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces Re-Launch of Rainbow Sherbet Cannabis-Infused Gummies for Pride 2020, SF Queer Nightlife Fund Collaboration

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp branded products company in California, today announced the re-launch of its best-selling* limited edition Rainbow Sherbet cannabis-infused gummies for Pride 2020. According to the update, the Company is collaborating with the SF Queer Nightlife Fund (the “SF QNF”) as part of its commitment to strengthening and supporting the communities in which it operates and sells products. Under the collaboration, Plus Products will donate $1 per tin sold to provide direct financial relief to workers in queer nightlife in San Francisco who have been affected by the COVID-19 pandemic. “The spirit of Pride is celebrating the LGBTQ community, and with social distancing measures in place, staying connected to our communities is more important than ever. Celebrating Pride is a tradition we’ve enjoyed participating in for the past few years,” Jake Heimark, CEO and co-founder of PLUS, said in the news release. “This year, in light of the COVID-19 pandemic, PLUS sought an opportunity to focus our impact on those within the LGBTQ community disproportionately affected by the financial hardships the pandemic has caused as we all shelter in place here in California. Nightlife is center stage for queer culture, history, and the continued advancement for LGBTQ rights in our country. People working to keep this integral part of queer life empowered and vibrant have suddenly found themselves out of work. The SF QNF has stepped in to help the most vulnerable members of their community in a time of great need.”

To view the full press release, visit http://ibn.fm/LgPdo

About PLUS
PLUS is a hemp and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable – that begins with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, CA. For more information, visit the Company’s website at www.PlusProducts.com.

*According to PLUS wholesale data, Rainbow Sherbet gummies have been the Company’s best-selling limited edition product

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

QualityStocksNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Completes Management Transition Process with Appointment of CEO, President

Sigma Labs (NASDAQ: SGLB), a leading provider of in-process, quality-assurance software for the additive manufacturing industry, recently appointed experienced software industry executive Mark K. Ruport as CEO and president (http://ibn.fm/oNSOj). The move finalizes the company’s management transition process. An article further discussing the new appointment reads, “In his new assignment, Ruport will leverage his experience with public and private software companies to lead Sigma Labs through a period of significant growth and success. ‘The ability to have an immediate, tangible impact on Sigma Labs with the apparent adoption of its incredible technology in the marketplace is a unique and exciting opportunity,’ Ruport said in a news release announcing his December appointment. ‘My focus will be on accelerating our commercial adoption with strategic partners and amplifying the recent success John [Rice] and his team have achieved. This blueprint is something I am very familiar with given my experience with disruptive companies in the software sector, and I look forward to working with the entire team at Sigma Labs to drive forward its strategic initiatives.’”

To view the full article, visit http://ibn.fm/TSMAQ

About Sigma Labs Inc.

Sigma Labs is a leading provider of quality-assurance software to the commercial 3D-metal-printing industry under the PrintRite3D(R) brand. Sigma is a software company that specializes in the development and commercialization of real-time, computer-aided inspection (“CAI”) solutions known as PrintRite3D for 3D advanced-manufacturing technologies. Sigma Labs’ advanced computer-aided software product revolutionizes commercial additive manufacturing, enabling nondestructive quality assurance mid-production, uniquely allowing errors to be corrected in real time. For more information, please visit www.SigmaLabsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Rebrands Investor Intelligence Platform

SRAX (NASDAQ: SRAX) recently announced the rebranding of its investor intelligence platform from SRAX IR to Sequire. An article further discussing the platform reads, “The investor-relations platform, which enables companies to monitor their shareholders’ buying and selling behavior and carry out virtual investor meetings among other services, announced that it had gained 59 corporate subscribers as of the end of 2019 — a remarkable 64% increase relative to the quarter ending Sept 30, 2019. . . . ‘We are thrilled to announce the new brand, giving the platform its own identity separate from SRAX,’ SRAX CEO and founder Christopher Miglino noted in a news release regarding the rebranding announcement (http://ibn.fm/tfKtt). ‘It’s also arriving at an opportune time as we are developing new intelligent technologies to further provide public companies the tools to reach and engage their shareholders.’”

To view the full article, visit http://ibn.fm/BAnLk

About SRAX

SRAX is a digital-marketing and consumer-data-management technology company. SRAX’s technology unlocks data for brands in the CPG, investor relations, luxury and lifestyle verticals. Through its various platforms, SRAX is monetizing its data sets and growing multiple recurring revenue streams. BIGtoken is a consumer-managed data marketplace where people can own and earn from their data. The platform also provides advertisers and media companies access to transparent, verified consumer data to better reach and serve audiences. Sequire is a premier platform for investor intelligence and communication. Through Sequire, public companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX and its verticals, visit www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Helomics Subsidiary Holds Unique Cancerous Tumor Inventory

Predictive Oncology (NASDAQ: POAI) CEO Dr. Carl Schwartz recently referred to the company’s Helomics subsidiary as a “major asset” during an exclusive NNW interview with Stuart Smith (http://ibn.fm/8knZX). An article discussing the interview reads, “During the interview, Schwartz pointed out that Helomics’ collection of more than 150,000 cancer tumors is the largest inventory of its kind in the world and that the impressive collection ‘was amassed over the last two decades by physicians sending in cancerous tumors to be tested with the known therapies of the time. The results of these tests were in turn sent back to the referring physicians to be used as a guide or a reference as desired for treatment of the evaluated tumor,’ he continued. ‘And the evaluated tumor was placed back in the physician’s therapy inventory. That’s how we amassed all these tumors.’ . . . Schwartz explained that POAI was intent on proving that it can sequence, ‘which is genetically profile our tumors, and do what is called a ‘reach back,’ or examination of what eventually happened to these patients over an extended period of time. I want to strongly emphasize that Helomics is the only company with the ability to do this ‘reach back’ at this time because only we have a patient history.’”

To view the full article, visit http://ibn.fm/ioxbt

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (domestic, international and other) that contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient-treatment decisions by providing an evidence-based road map for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled with a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform Kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient-specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Enlists Rare Earth Experts in Developing Commercial, Technical Strategies

- UUUU has finalized consulting agreements with two rare earth element industry experts
- Constantine Karayannopoulos and Brock O’Kelley will assist Energy Fuels as it focuses on entering rare earth space in the United States
- Energy Fuels seeking to leverage existing U.S. facility to produce high-value rare earth concentrates

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), the largest producer of uranium and the leading conventional producer of vanadium in the United States, has announced that it has finalized agreements with Constantine Karayannopoulos and Brock O’Kelley, two rare earth element (REE) industry experts, to consult with the company in the development and implementation of commercial and technical REE strategies for the new U.S. REE program (http://ibn.fm/TWVaK). The company previously announced that it is entering the U.S. rare earths space by potentially leveraging its existing White Mesa Mill in Utah to produce high-value rare earth concentrates. If successful, the mill would play a critical role in restoring a U.S. rare earths supply chain.

“Energy Fuels is extremely excited to bring Constantine Karayannopoulos and Brock O’Kelley on board to advance our entry into the rare earth space in the U.S.,” UUUU President and CEO Mark S. Chalmers stated in a news release. “Over the past year or so, Energy Fuels has been actively evaluating this rare earth opportunity. We are quickly coming to the conclusion that the White Mesa Mill may be an ideal U.S. facility to process rare earth element ore streams and produce rare earth concentrates. Mr. Karayannopoulos and Mr. O’Kelley will assist Energy Fuels in the commercial and technical aspects of this endeavor.”

A chemical engineer by training with more than 25 years of experience in the rare earth industry, Karayannopoulos currently serves as chairman of Neo Performance Materials, one of the world’s leading producers of rare earth engineered and magnetic materials, with integrated supply chains across the globe. O’Kelley played a critical part in the operation of the Mountain Pass, California, rare earth processing facility for several decades. Both are industry veterans with extensive knowledge of REE processing facility design, start-up, operations and downstream value-added manufacturing of advanced REE products.

The consulting agreements represent Energy Fuel’s commitment to pursue the commercially viable REE production capacity in the United States. UUUU is currently evaluating minor modifications to its licenses and operations designed to enable the processing of uranium- and thorium-bearing rare earth ores at the White Mesa Mill facility in Utah. Removal and recovery of the uranium and thorium from rare earth ores is central to Energy Fuels’ value proposition, as many rare earth separation and recovery facilities are not able to handle uranium or thorium from a technical or regulatory standpoint. While adding this component to its business operations, Energy Fuels intends to continue its focus on uranium mining and production operations, and simply enhancing that production by recovering the contained uranium from REE ores for sale into the nuclear fuel cycle in a manner similar to how China’s rare earth and nuclear fuel industries work together.

“Energy Fuels looks forward to working with these two industry veterans in developing our REE business in the U.S. and in advancing our relationships in this sector,” added Chalmers. “Between Mr. Karayannopoulos, Mr. O’Kelley, and ANSTO of Sydney, Australia, we believe Energy Fuels is truly assembling a topflight team capable of building a successful U.S. REE business.”

Based in Lakewood, Colorado, Energy Fuels holds three of America’s key uranium production centers: the Nichols Ranch (ISR) project in Wyoming, the Alta Mesa ISR Project in Texas and the White Mesa Mill in Utah – the only conventional uranium mill operating in the United States today with a licensed capacity of more than 8 million pounds of U3O8 per year. With an asset portfolio that boasts more uranium production facilities, in-ground resources, production capacity and experienced personnel than any other producer, Energy Fuels is in a unique position to maintain its position as the leading producer of uranium in an era of viable transformation of the U.S. nuclear industry.

For more information, visit the company’s website at www.EnergyFuels.com

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

QualityStocksNewsBreaks – Sharing Services Global Corporation’s (SHRG) Elevate MAX Sales Surpass All Prior Product Launches

Sharing Services Global (OTCQB: SHRG), a diversified holding corporation, recently reported that sales of Elevate MAX, a new featured beverage in its Elevacity nootropic product line, have exceeded the company’s expectations and surpassed all previous product launches. A recent article discussing the new product reads, “Elevate MAX is more than just a cup of coffee; this ‘happy coffee’ targets increasing consumer demands for additional functional beverages with potential health benefits such as weight management, mood enhancement and extreme energy (http://ibn.fm/qwDVY). . . . ‘We completed extensive market research with outstanding results and are pleased to report the sales of Elevate MAX has exceeded our expectations and surpassed any prior product launches,’ Keith Halls, president and CEO of Elepreneurs Holdings LLC, the sales and marketing subsidiary that manages and operates the network of distributors selling the Elevacity product line, stated in a news release.”

To view the full article, visit http://ibn.fm/upaYg

About Sharing Services Global Corporation

Sharing Services Global, formerly Sharing Services Inc., is a publicly traded, diversified company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies in the direct-selling industry. The company’s combined platform leverages the capabilities and expertise of various companies that market and sell products direct to the consumer through independent contractors. Two of its primary divisions include Elevacity Global LLC, a product sourcing and supply company, and Elepreneur LLC, a sales and marketing company based on utilization of independent contractors as the sales force. For more information, visit www.SHRGInc.com, www.Elevacity.com or www.Elepreneur.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Featured in Global Small Cap Research Report

Sugarmade (OTCQB: SGMD) was recently the subject of a report conducted by Global Small Cap Research (http://ibn.fm/1Mca5). An article discussing the report reads, “Outlining what it called a ‘near-perfect business world’ for cannabis delivery operators, the report made a strong case by observing that ‘Sugamade is enjoying participation in a rapidly growing market. . . . Few if any, marketplaces are growing faster than cannabis — and the California market is the epicenter of growth.’ The report stated that during 2019, the cannabis market produced approximately $100 billion in U.S sales, with growth projected to top 32% compounded annually over the next few years. . . . In addition, the reported noted that a general trend for home-delivery service, a favorable labor environment, the advantages of being publicly traded and a disrupted industry that has become even more shattered as a result of the COVID-19 pandemic all combine to create a ‘positive outlook for Sugarmade for the rest of 2020 and into next year. At a time when so many businesses are struggling, we believe companies involved in certain areas of the cannabis marketplace, such as delivery services, are not only surviving, but thriving,’ the report concluded.”

To view the full article, visit http://ibn.fm/yNWzC

About Sugarmade Inc.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. More information on Sugarmade can be found at www.Sugarmade.com. Sugarmade sees opportunities in business operations that combine the best areas of on-demand consumer distribution with certain areas of synergistic manufacturing and packaging to create a business model that capitalizes on the many changes in the cannabis industry. The company has made agreements with several market participants, which will be announced this year. The company views these opportunities as scalable and capable of producing strong revenue growth for the company.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

National Storm Recovery Inc. (NSRI) Ideally Positioned in Growing Billion-Dollar Industry

- Restoration industry worth an estimated $210 billion, expected to increase in value with the increasing number of natural disasters
- An average of 15 billion-dollar disasters occurred each year from 2015 through 2018, while the average prior to that was 6.2 events per year
- With more than 40 years of experience, National Storm Recovery is a seasoned provider of storm/disaster recovery services

Recent studies indicate that the restoration industry as a whole is worth an estimated $210 billion (http://ibn.fm/GmgCp) and is expected to only increase in value with the increasing intensity and number of natural disasters. With experts predicting that the disaster recovery and restoration sector will only continue its upward trajectory, National Storm Recovery Inc. (OTC: NSRI) looks to be in an ideal position to ride the wave and benefit from the storm and disaster recovery solutions it provides.

A recently updated CNBC report focusing on the disaster recovery and property restoration noted that about 74% of restoration companies experienced sales growth; the same article (http://ibn.fm/X27N5) stated that “with some predicting wilder weather in the future due to climate change, the horizon [for the industry] looks limitless.”

Costly natural disasters have been proven to be on the uptick. A second CNBC article (http://ibn.fm/zkAG5) reported that “over each of the past three years, an average of 15 billion-dollar disasters have occurred, while the average for 1980-2018 was just 6.2 events per year. The number of billion-dollar disasters is clearly trending upward, writes Adam B. Smith, a climate scientist with the NOAA.”

With more than 40 years of experience, National Storm Recovery is a seasoned provider of storm/disaster recovery services. The company, through its subsidiaries, provides tree services, debris hauling, biomass recycling and mulch manufacturing. NSRI’s satisfied customers come from the governmental, residential and commercial sectors.

Headquartered in Jacksonville, Florida, NSRI and its subsidiaries provide expert and professional tree services, debris hauling, biomass recycling and mulch-manufacturing options to governmental, residential and commercial customers. NSRI’s solutions, provided by its Sustainable Green Team, are rooted in sound principles designed to benefit the environment. NSRI offers the best equipment and time-proven strategies, along with an unwavering commitment to customer service.

The CNBC article noted that “investors may find the disaster-recovery sector highly profitable but hard to break into unless they are franchisees, mostly because there are few publicly traded options.” NSRI may offer an attractive option for investors looking at the promising future of disaster recovery and restoration.

NSRSI’s commitment is to environmentally beneficial solutions to tree and storm-waste disposal (http://ibn.fm/JyHg9). For investors, the company plans to expand its operations through a combination of organic growth, including its partnership with a nationally recognized waste disposal company and via strategic acquisitions. NSRI’s next-level experience with mulch manufacturing, treatment and caring for trees sets it on the right course for sustained growth.

For more information, visit the company’s website at www.NationalArborCare.com

NOTE TO INVESTORS: The latest news and updates relating to NSRI are available in the company’s newsroom at http://ibn.fm/NSRI

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Announces AGM 2020 Results, Election of New Director

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) on Thursday announced the election of each of the seven individuals nominated as a director of VIVO at the company’s Annual General and Special Meeting of Shareholders held on May 28, 2020. According to the update, VIVO management nominated each of the existing directors, together with new nominee, Christie Henderson, for election at the meeting. Henderson is the managing partner and CEO of Henderson Partners LLP, a firm of chartered professional accountants and advisors, as well as a certified corporate director (“ICD.D”). She has more than 20 years of experience with consumer products, retail, real estate, brewery, food and professional service industries and private equity, is an experienced board chair, and has served on various governance, audit and risk committees. “Christie is an outstanding addition to the Board and will bolster our commitment to being an industry leader in corporate governance,” VIVO’s CEO Barry Fishman said in the news release. “Having the counsel of one of Canada’s top female entrepreneurs is a tremendous asset and we look forward to benefiting from her expertise in a variety of areas, including financial and enterprise risk management as well as corporate strategy and performance.”

To view the full press release, visit http://ibn.fm/OMkic

About VIVO Cannabis(TM)

VIVO Cannabis(TM) is recognized for trusted, premium cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities with proprietary plant-growing technology in Hope, British Columbia and Napanee, Ontario. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms(TM), Beacon Medical(TM), Fireside(TM), Lumina(TM) and Canadian Bud Collection(TM). The Company is expanding its production capabilities and distribution network. Harvest Medicine, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 100,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. The company has a healthy balance sheet and is well-positioned to accelerate its path to profitability. For more information, visit www.VIVOCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF

QualityStocksNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Reports Financial Results for Q1 2020

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis branded products company in the U.S., on Thursday released its unaudited financial and operational results for the three months ended March 31, 2020, expressed in U.S. dollars. Among other highlights, the company reported an increase in net revenues to $4.7 million in Q1 2020, representing a 46% year-over-year growth as compared to Q1 2019, as well as a 36% quarter-over-quarter growth as compared to Q4 2019. “The start of this year came with a number of difficult decisions that were made in order to accelerate our path to cash flow generation,” Jake Heimark, co-founder and CEO of Plus Products, stated in the news release. “The changes we made helped to cut our cash consumption to less than a fifth of what it was last quarter and, critically, doing so did not undermine our core business which grew more than 35% quarter-over-quarter.”

To view the full press release, visit http://ibn.fm/RHKk4

About Plus Products

PLUS is a cannabis and hemp food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable, beginning with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, California. For more information, visit the company’s website at www.PlusProducts.com.

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Voluntary Share Lock-Up, Engagement of Gold Standard Media for Marketing and Consulting Services

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, today announced that certain shareholders have agreed to a voluntary resale restriction period covering 17,840,000 common shares extending the period of time before the shares become free trading to July 15, 2020. According to the update, these shares were previously only subject to a statutory hold period. In addition, Champignon Brands also announced its engagement of Gold Standard Media, LLC (“GSM”) to provide marketing and consulting services to raise public awareness of the company, with a specific emphasis on its North American clinical expansion. GSM is a Georgetown, TX-based limited liability company existing under the laws of the state of Texas.

To view the full press release, visit http://ibn.fm/PElmi

About Champignon Brands Inc.

Champignon Brands is focused on the formulation and manufacturing of novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutraceutical and psychedelic medicine while being supported by a leading psychedelics medicines clinic platform. The company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (“PTSD”), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the company is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For more information, visit the company’s website at www.ChampignonBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM

QualityStocksNewsBreaks – ChineseInvestors.com Inc. (CIIX) CEO Confirms Revenue Numbers, Discusses CBD Biotech on MoneyTV with Donald Baillargeon

ChineseInvestors.com (OTCQB: CIIX) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program, viewed in over 200 million households and more than 75 countries, covers money-focused topics and features in-depth interviews with CEOs and executives offering insights into various companies and their operations and future outlooks. Among other highlights, this week’s episode featured CEO Warren Wang as he confirmed revenue numbers and success of the company’s trading service on YouTube, as well as revealed plans for CBD Biotech.

To view the full press release, visit http://ibn.fm/xk3lN

About ChineseInvestors.com Inc.

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company by providing (a) real-time market commentary, analysis and educationally related services in both traditional and simplified Chinese language character sets; (b) advertising and public-relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health-related products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Q1 Revenue, 1606 Original Hemp Sales on MoneyTV with Donald Baillargeon

SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. Among other highlights from this week’s program, SinglePoint CEO Greg Lambrecht discussed the company’s first quarter revenue and outlook for 2020. Lambrecht also provided an overview of the company’s Direct Solar America and 1606 Hemp subsidiaries. “Our website, 1606Hemp.com, is starting to experience a lot of online sales as we do more marketing, particularly with influencers,” SinglePoint CEO Greg Lambrecht stated in the interview. “We’re really taking advantage of that new wave of doing business with influencers. I think we’re up over 10,000 followers.”

To view the full press releases, visit http://ibn.fm/00K9U and http://ibn.fm/b8FmD

About SinglePoint, Inc.

Founded in 2011, SinglePoint, Inc. invests in and acquires brands and companies that will benefit from injection of growth capital and its sales and marketing expertise. The company’s portfolio currently includes solar, hemp and technology applications. SinglePoint is working to grow the company to a multi-national brand. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Partners with Source Digital to Launch Digital Advertising Campaign

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) recently developed a partnership with Source Digital, a pioneer in immersive commerce using digital-media platforms and video content on the internet. An article discussing the company reads, “This unique campaign will use Source’s patented advertising technology to deliver PowerBand’s cloud-based transaction platform, which makes selling or buying a vehicle just as easy as selling or buying a product on Amazon or eBay (http://ibn.fm/i0VgR), to millions of consumers. . . . ‘With PowerBand, you can use your smartphone or laptop to buy, sell, lease, trade or finance a vehicle, often in seconds. We believe it’s important to get PowerBand’s transaction platform into the hands of both dealers and consumers, to help them in this current economic crisis and navigate the new reality, in which consumers and dealers must be more digitally connected,’ PowerBand CEO Kelly Jennings stated in a news release. ‘Source will bring PowerBand’s virtual transaction platform to people who need it.’”

To view the full article, visit http://ibn.fm/duTMu

About PowerBand Solutions Inc.

PowerBand Solutions, listed on the TSX Venture Exchange and the OTCQB markets, is a fintech provider disrupting the automotive industry. PowerBand’s integrated, cloud-based transaction platform facilitates transactions among consumers, dealers, funders and manufacturers (“OEMs”). The platform enables these entities to buy, sell, trade, finance and lease new and used, electric and nonelectric vehicles on smartphones or other online digital devices from any location. PowerBand’s transaction platform —trademarked under DRIVRZ — is being made available across North American and global markets. For more information, visit www.PowerBandSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to PWWBF are available in the company’s newsroom at http://ibn.fm/PWWBF

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSX.V: ISGI) Expanding Service Offerings in Response to Rising Insurtech Solutions Demand

InsuraGuest Technologies (TSX.V: ISGI) offers innovative ideas and solutions to revolutionize outdated business models and systems. A recent article discussing the company reads, “It took a while, but insurtech is now giving fintech a run for its money. Slow off the starting block, innovation in the insurance industry is currently outpacing digital developments in banking, payments and other financial technologies. As a result, traditional insurers are turning to companies, such as InsuraGuest Technologies Inc. (TSX.V: ISGI), that offer cutting-edge ideas and solutions to revamp antiquated business models and systems. Consequently, InsuraGuest plans to increase its range of services to meet the growing demand for insurtech solutions. Digitizing insurance services is widely expected to reduce operating costs and increase customer satisfaction during the sign-up, renewal and claims processes. . . . A recent report from industry analyst Grand View Research paints a picture of potential for the fledgling insurtech industry. Valued at just $1.5 billion in 2018, the market is forecast to cross $18 billion in 2025, experiencing a CAGR of 43% from 2019 until then (http://ibn.fm/zTkcb). Spending by incumbent insurers has caused investment in the insurtech sector to double that in the fintech sector, growth of which is projected at 22% (http://ibn.fm/FfU87).”

To view the full article, visit http://ibn.fm/9ehp7

About InsuraGuest Technologies Inc.

InsuraGuest is a software company that utilizes its proprietary insurtech (insurance + technology) platform to deliver digital insurance to its customers. ISGI’s first product, InsuraGuest Hospitality, delivers custom Hospitality Liability coverages to hotels and vacation rentals. InsuraGuest coverages are purchased by hotels and vacation-rental properties, which can address covered claims from their guests and room occupants during their stays. For more information, visit www.InsuraGuest.com.

NOTE TO INVESTORS: The latest news and updates relating to ISGI are available in the company’s newsroom at http://ibn.fm/ISGI

QualityStocksNewsBreaks – Hemptown Organics Corp. Announces Strategic Board Appointments to Further Enhance Products and Services, Expand Global Reach

Hemptown Organics on Wednesday announced the appointment of Janice Knox and Siddhartha “Sid” Senroy to its Advisory Board. “We are excited for what the future holds for Hemptown. We strongly believe with the help of our highly equipped Advisory Board, that we will take the Company to new heights in 2020 and beyond,” Eric Gripentrog, CEO of Hemptown, said in the news release. “These two exceptional individuals are at the forefront of their respective industries, and we know with their support and expertise that we will enhance our products and services, ultimately increasing Hemptown’s reach globally.”

To view the full press release, visit http://ibn.fm/UHwve

About Hemptown Organics Corp.

Hemptown is growing some of the finest hemp in the world to meet the global demand for cannabinoid-based products. Farmland spanning three states, product manufacturing capability and a strong leadership team are the pillars for Hemptown’s growth model as the Company pushes into the consumer-packaged goods sectors with top quality white label and branded product lines for the consumer market. Hemptown’s fully operational (FDA-licensed and cGMP certified) nutraceutical manufacturing facility in Oregon gives the company a strong leadership position in a global market that continues to grow exponentially. For more information, visit www.HemptownUSA.com.

QualityStocksNewsBreaks – The Movie Studio, Inc. (MVES) Shares Several Major Material Events in Corporate Overview

The Movie Studio (OTC: MVES), a vertically integrated motion picture production company engaged in the acquisition, development, production and distribution of independent motion picture content for worldwide consumption, today provided its corporate overview from MVES President and CEO Gordon Scott Venters. “We are excited to share several major material events that have occurred as part of the expansion of our vertically integrated film production and distribution architecture utilizing over-the-top (“OTT”) distribution platforms and blockchain technology. We have recently integrated a platform that enables worldwide distribution of licensed movie content (http://ibn.fm/74f67),” Venters stated in the update. “We also recently announced that The Movie Studio has licensed several films, including ‘Bad Actress’ and ‘Exposure,’ for distribution in Australia (http://ibn.fm/PpzSM). MVES has additionally signed an agreement with Filmhub for the licensing and distribution of motion pictures (http://ibn.fm/6eVNh). We further recently entered into a memorandum of understanding with BINGE Networks LLC, an award-winning streaming media platform, providing the ability to globally and instantly syndicate and monetize content for the streaming media industry (http://ibn.fm/VL4aQ).”

To view the full press release, visit http://ibn.fm/CvgS3

About The Movie Studio, Inc.

The Movie Studio, Inc. operates as a vertically integrated motion picture production and distribution company. The company acquires, develops, produces and distributes independent motion picture content for worldwide consumption via theatrical release, video on demand, foreign sales, and various media devices. It is disrupting traditional media content delivery systems with its digital business model of motion picture distribution and intends direct server access of its content with geo-fractured territories for worldwide distribution. The company was formerly known as Destination Television, Inc. and changed its name to The Movie Studio, Inc. in November 2012. The Movie Studio, Inc. was founded in 1961 and is headquartered in Fort Lauderdale, Florida. For more information, visit www.TheMovieStudio.com.

NOTE TO INVESTORS: The latest news and updates relating to MVES are available in the company’s newsroom at http://ibn.fm/MVES

QualityStocksNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Announces Sales from Latest Harvest at Strong 11% Premium to Current Industry Benchmarks

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced that recent sales from its latest harvest have earned unit pricing at a strong 11% premium to current industry standard benchmarks for cannabis sales on a per pound basis. According to CannabisBenchmarks.com, U.S. cannabis sales currently average roughly $1,525 per pound. From six months ago to now, Cannabis Strategic Ventures has transitioned from selling at a discount to now selling at a premium relative to benchmark levels, with pricing of recent sales at approximately $1,700 per pound. “We have seen a steady improvement in per pound pricing driven by improving quality mostly as a consequence of better operational execution at NUGS Farm,” Simon Yu, CEO of Cannabis Strategic Ventures, stated in the news release. “It also represents another signal that we are heading in the right direction in terms of our core objectives: expanding production capacity, expanding sales volume, and expanding profitability on a per unit basis.”

To view the full press release, visit http://ibn.fm/rYA6M

About Cannabis Strategic Ventures

Cannabis Strategic Ventures, Inc. (OTC: NUGS) is one of the largest publicly traded marijuana cultivators in the United States. The company is Los Angeles-based that incubates, develops and partners with category leaders within the cannabis and ancillary sectors. The firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands. For more information, visit www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Secures $2.5 Million in Cash Proceeds from Recent Warrant Exercises

Genprex (NASDAQ: GNPX) today announced the exercise of warrants to purchase approximately 5.4 million shares of common stock issued in connection with capital raises in May 2018 and November 2019 with two institutional investors at a price of $0.46 per share, resulting in its receipt of approximately $2.5 million in cash proceeds. According to the update, the warrants were exercised on or about May 22, 2020, the first day they became exercisable under their respective agreement terms. The exercised warrants represent approximately 70% of the company’s overall outstanding warrants and include all warrants that have been issued to investors in the company’s public financings to date. After the exercise, remaining warrants carry a weighted average exercise price of approximately $3.93. Genprex believes the elimination of the majority of its outstanding warrants represents a significant milestone for the company, providing a dramatically simplified capital structure.

To view the full press release, visit http://ibn.fm/1QWNi

About Genprex, Inc.

Genprex, Inc. is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The Company’s lead product candidate, Oncoprex(TM), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). Oncoprex has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for Oncoprex immunogene therapy for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)). For more information, please visit the company’s website at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX